GENEVA
One million of doses of two experimental Ebola vaccines will be produced in 2015, the World Health Organization said on Friday.
The use of the two candidate vaccines -- one from the private drug producer GlaxoSmithKline, and another from the Public Health Agency of Canada -- will depend on their success in trials, WHO Assistant Director-General for Health Systems and Innovation Dr. Marie Paule Kieny said in a press conference in WHO headquarters in Geneva.
Other than these two experimental Ebola vaccines, five more possible Ebola vaccines are expected to begin testing in the first half of next year, she said.
Kieny said "a few hundred thousand will be produced in the first half of the year," adding that "l am not saying all of these will be used."
Kieny emphasized the importance of the trials. "Let's be clear that they are still candidate vaccines," she insisted.
